2022
DOI: 10.1016/j.ijregi.2022.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of H. pylori among asymptomatic HIV-positive and negative individuals in Central Ethiopia and efficacy of eradication therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 28 publications
0
3
1
Order By: Relevance
“…In this study, the H. pylori eradication rate using standard triple therapy was 83.8% (244/291). This result was lower than the eradication rate reported from Northern Ethiopia, which was 90.3% [ 27 ] and higher than the study reported from Central Ethiopia, which was 50.0% [ 40 ]. Moreover, our findings are comparable with a recent systematic review on eradication rate of African studies, which was 79.0% [ 41 ].…”
Section: Discussioncontrasting
confidence: 71%
“…In this study, the H. pylori eradication rate using standard triple therapy was 83.8% (244/291). This result was lower than the eradication rate reported from Northern Ethiopia, which was 90.3% [ 27 ] and higher than the study reported from Central Ethiopia, which was 50.0% [ 40 ]. Moreover, our findings are comparable with a recent systematic review on eradication rate of African studies, which was 79.0% [ 41 ].…”
Section: Discussioncontrasting
confidence: 71%
“…In addition to the data in the tables, some local reports of data deserve citation. The prevalence of the H. pylori-HIV co-infection in single-center studies was 32.6% in Busan (Republic of Korea in the year 2019) using the serology method, 69.7% in Tehran (Iran in the year 2011) using the stool genotyping method, and 78.1% vs. 75.1% at Assela (Ethiopia in the year 2017) using the stool antigen method among asymptomatic individuals with and without HIV infection, respectively [23][24][25]. At Bologna in Italy, the prevalence was 55% and 58% by serology among asymptomatic past-intravenous drug users versus the general population, respectively, tested by serology, and 40% and 66% among symptomatic past-intravenous drug users versus the general population, respectively, tested by pathology [26].…”
Section: Resultsmentioning
confidence: 99%
“…The literature has been acknowledging for a few years now that Helicobacter pylori is linked to several extra-gastric disorders. One of the most prevalent chronic infections globally is Helicobacter pylori , with prevalence rates ranging from 35 per cent in high-income nations (Zamani et al, 2018; Mesfun et al, 2022) to 79–90% in low-income nations (Asrat et al, 2004a,b; Hooi et al, 2017; Mesfun et al, 2022). Most of the time, the infection is asymptomatic, but it can also cause non-malignant problems including iron-deficiency anaemia, dyspeptic illness, and malignant complications like gastric and oesophagal cancer (Xie et al, 2013; Mesfun et al, 2022).…”
Section: Introductionmentioning
confidence: 99%